Transpek Industry Limited (506687) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Transpek Industry Limited ₹1,176, price ₹1,310, upside -10.2%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Transpek Industry Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range ₹876.30 – ₹2,408 · fair‑value band ₹785.96 – ₹1,575 · the ₹1,310 price screens above the ₹1,176 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Transpek Industry in your weekly email
Every Wednesday you see whether Transpek Industry is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Transpek Industry Limited manufactures and sells chemical products in India.
Show more
Transpek Industry Limited manufactures and sells chemical products in India. The company offers 2, 4, 6 trimethyl benzoyl chloride, 2-chloroethylamine hydrochloride solution, 2-ethylhexanoyl chloride, 2-methoxyethyl chloride, 2-propoxyethyl chloride, 4-chlorobutyryl chloride, cocoyl chloride, diethylene glycol dichloride, isobutyryl chloride, isononanoyl chloride, isophthaloyl chloride, and lauroyl chloride. It also provides m-nitrobenzoyl chloride, methoxyacetyl chloride, n-butyryl chloride, n-decanoyl chloride, n-octyl chloride, n-valeroyl chloride, neodecanoyl chloride, o-toluoyl chloride, octanoyl chloride, p-nitrobenzoyl chloride, pivaloyl chloride, propargyl chloride solution, sulphur dichloride, sulphur monochloride, terephthaloyl chloride, triethyleneglycol dichloride, and thionyl chloride. The company serves customers in various industries, including textiles, pharmaceuticals, agrochemicals, advanced polymers, etc. Transpek Industry Limited also exports its products. The company was founded in 1965 and is headquartered in Vadodara, India.
Stock analysis
Transpek Industry Limited (506687) currently trades at ₹1,310, while our model-based Fair Value estimate is ₹1,176, 10.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹1,389 per share, and 9 of the 24 models we run sit above the ₹1,310 price.
Bear case: the Economic Profit group reads lowest at ₹423.98, and 15 of the 24 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹785.96 (bear) to ₹1,575 (bull), the price of ₹1,310 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Other sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Transpek Industry Limited reported revenue of ₹6.2B in FY2026 versus ₹6.0B in FY2022, a compound +0.9%/yr. Reported net income was ₹456M in FY2026, compounding −8.6%/yr from FY2022.
Key figures
Market cap ₹10.7B (≈ $111M) · P/E ratio 11.5 · P/S ratio 0.84 · EPS (TTM) ₹104.67 · Dividend yield 0.2% · Net margin 7.3% · Return on equity 17.5% · Return on assets (EBIT) 7.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 11% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Other peers we cover trades at −10% fair-value upside, at −10%, 506687 screens richer than that median.
Fair Value models
Bear ₹785.96Fair Value ₹1,176Bull ₹1,575
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹52.06 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
Start year 2021 (pandemic). Over 10 years: +8.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.9%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.9% vs 4.3%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 7%
Start year 2021 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+15.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +10.5% a year for the price.
Compare Transpek Industry Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 165 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score61 · Top 25%
Fair Value upside−10.2% · Below median
Profitability
Return on equity (TTM)17.5% · Top 25%
Return on assets9.3% · Top 25%
Net margin (TTM)11.9% · Top 25%
Operating margin (TTM)17.5% · Top 25%
Growth and dividend
Revenue growth−37.5% · Bottom 25%
Dividend yield (TTM)0.2% · Below median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Other median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Transpek Industry Limited Fair Value". https://www.fairvalue-calculator.com/stock/506687
Frequently asked questions
Is Transpek Industry Limited (506687) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of ₹1,176 versus a price of ₹1,310, about −10% upside (overvalued).
What is the fair value of 506687?
Our model-based fair value for Transpek Industry Limited is ₹1,176 (as of Oct 3, 2026), built from audited fundamentals. The current price: ₹1,310.
What is the quality score of 506687?
Transpek Industry Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Transpek Industry Limited (506687)?
Our model-based price target is the fair value of ₹1,176 (as of Oct 3, 2026) from 24 valuation models. Cautious scenario ₹785.96, optimistic scenario ₹1,575. It is a calculation from audited fundamentals, not an analyst target.
What is the Transpek Industry Limited stock forecast for 2026?
Our models put fair value at ₹1,176, about −10% upside versus a price of ₹1,310 (overvalued). Cautious scenario ₹785.96, optimistic scenario ₹1,575. The calculation is refreshed regularly with new filings.
What is the revenue of Transpek Industry Limited (506687)?
Transpek Industry Limited reported trailing-twelve-month revenue of about ₹4.9B (latest available figure, as of Oct 3, 2026).
Does Transpek Industry Limited pay a dividend?
Transpek Industry Limited currently shows a dividend yield of about 0.19% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Transpek Industry Limited (506687)?
For today's price to be fair in a discounted-cash-flow model, Transpek Industry Limited would have to grow free cash flow by +15.1 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.9 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of 506687 use?
Our models discount Transpek Industry Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.14, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Transpek Industry Limited that is +15.1 % per year a year over ten years, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Transpek Industry Limited (506687) delivered so far?
Over the past 5 years revenue at Transpek Industry Limited grew +12.9 % a year. The price currently implies +15.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Transpek Industry Limited (506687) growing?
The median revenue growth in the sector is +8.0 % a year. That is the yardstick for the growth priced into Transpek Industry Limited (+15.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Transpek Industry Limited (506687)?
The free-cash-flow yield on the price is 5.50 %: that much free cash flow Transpek Industry Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Transpek Industry Limited (506687)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Transpek Industry Limited it is ₹1,176 per share (as of Oct 3, 2026), against a price of ₹1,310. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Transpek Industry Limited stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 506687 trades above its calculated fair value: price ₹1,310, fair value ₹1,176, a gap of about −10% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 506687?
No. The price is what the market pays today (₹1,310); the fair value is what the company's own numbers justify (₹1,176). For Transpek Industry Limited the two are ₹133.99 per share apart. That gap is exactly why we show both numbers side by side.
How much is Transpek Industry Limited worth?
The market values Transpek Industry Limited at about ₹10.7B (market capitalisation, as of Oct 3, 2026). Per share that is ₹1,310; our models calculate a fair value of ₹1,176 per share.
What do the bullish and bearish scenarios say about 506687?
Our models span a range for Transpek Industry Limited: cautious scenario ₹785.96, base ₹1,176, optimistic ₹1,575 per share (as of Oct 3, 2026, price ₹1,310). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 506687?
Transpek Industry Limited trades at a price-to-earnings ratio of 11.5 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹1,176 is built from several models across several years. Other multiples: P/B 1.4, P/S 2.2, EV/EBITDA 9.8.
How solid is the balance sheet of Transpek Industry Limited (506687)?
Balance-sheet figures for Transpek Industry Limited (as of Oct 3, 2026): return on equity 17.5%, debt of 0.02 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is 506687 from its 52-week high?
Transpek Industry Limited trades at ₹1,310, about 11% below its 52-week high of ₹1,478 and 49% above the low of ₹876.30 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹1,176 is for.
Which stocks are comparable to Transpek Industry Limited?
From the same area (Other) we also value 542772, 590024, Indiabulls Real Estate Limited, KSB Pumps Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Transpek Industry Limited stock attractive at the current price?
The data as of Oct 3, 2026: price ₹1,310, calculated fair value ₹1,176 (−10%), Quality Score 61/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 506687 calculated?
We run Transpek Industry Limited through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹1,176, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Transpek Industry Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Transpek Industry Limited (506687)?
The closing price on Oct 1, 2026 was ₹1,310. Our model-based fair value is ₹1,176, about −10% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Transpek Industry Limited right now?
A fairly wide model range (₹785.96 to ₹1,575) leaves room in how you read the outcome. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Transpek Industry Limited
How large is the market capitalisation of Transpek Industry Limited (506687)?
The market capitalisation of Transpek Industry Limited is ₹10.7B (≈ $111M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Transpek Industry Limited (506687)?
The price-to-sales ratio of Transpek Industry Limited is 0.84 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Transpek Industry Limited (506687)?
Earnings per share at Transpek Industry Limited are ₹104.67 (price ÷ EPS = P/E 11.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Transpek Industry Limited (506687)?
The dividend yield of Transpek Industry Limited is 0.2% (payout 2.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Transpek Industry Limited (506687)?
The net margin of Transpek Industry Limited is 7.3% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Transpek Industry Limited (506687)?
The return on equity (ROE) of Transpek Industry Limited is 17.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Transpek Industry Limited (506687)?
On an EBIT basis the return on assets of Transpek Industry Limited is 7.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Transpek Industry Limited (506687)?
The operating margin of Transpek Industry Limited is 17.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Transpek Industry Limited (506687)?
Revenue at Transpek Industry Limited is growing −37.5% versus a year earlier (3y avg −9.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Transpek Industry Limited (506687)?
Earnings per share at Transpek Industry Limited are growing −96.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Transpek Industry Limited (506687) carry?
The net debt of Transpek Industry Limited is ₹361M (fiscal year 2024, ≈ 0.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Transpek Industry Limited in the live analysis
One click puts Transpek Industry Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
